Literature DB >> 32215553

Ceramide Biomarkers Predictive of Cardiovascular Disease Risk Increase in Healthy Older Adults After Bed Rest.

Jonathan J Petrocelli1, Alec I McKenzie1, Ziad S Mahmassani1, Paul T Reidy1, Gregory J Stoddard2, Annelise M Poss3, William L Holland3, Scott A Summers3, Micah J Drummond1.   

Abstract

Acute bed rest places older adults at risk for health complications by disrupting homeostasis in many organ systems, including the cardiovascular system. Circulating ceramides are emerging biomarkers predictive of cardiovascular and metabolic health and have recently been shown to be sensitive indices of cardiovascular (CV) risk. Therefore, the purpose of this study was to characterize the time course of changes in circulating ceramides in healthy younger and older adults after 5 days of bed rest and to determine whether short-term bed rest alters CV-related circulating ceramides. We hypothesized that circulating ceramides predictive of poor cardiometabolic outcomes would increase following 5 days of bed rest. Thirty-five healthy younger and older men and women (young: n = 13, old: n = 22) underwent 5 days of controlled bed rest. Fasting blood samples collected daily during the course of bed rest were used to measure circulating ceramides, lipoproteins, adiponectin, and fibroblast growth factor 21 (FGF21) levels. The primary findings were that circulating ceramides decreased while ceramide ratios and the cardiac event risk test 1 score were increased primarily in older adults, and these findings were independent of changes in circulating lipoprotein levels. Additionally, we found that changes in circulating adiponectin, FGF21 and the 6-minute walk test (6MW) inversely correlated with CV-related circulating ceramides after bed rest. The results of this study highlight the sensitivity of circulating ceramides to detect potential CV dysfunction that may occur with acute physical disuse in aging.
© The Author(s) 2020. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Blood lipids; CV risk factors; Disuse; Inactivity; Sphingolipids

Mesh:

Substances:

Year:  2020        PMID: 32215553      PMCID: PMC7494040          DOI: 10.1093/gerona/glaa072

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  50 in total

1.  Cardiovascular adaptations to long-duration head-down bed rest.

Authors:  Steven H Platts; David S Martin; Michael B Stenger; Sondra A Perez; L Christine Ribeiro; Richard Summers; Janice V Meck
Journal:  Aviat Space Environ Med       Date:  2009-05

2.  A ceramide-centric view of insulin resistance.

Authors:  Jose A Chavez; Scott A Summers
Journal:  Cell Metab       Date:  2012-05-02       Impact factor: 27.287

3.  One Week of Bed Rest Leads to Substantial Muscle Atrophy and Induces Whole-Body Insulin Resistance in the Absence of Skeletal Muscle Lipid Accumulation.

Authors:  Marlou L Dirks; Benjamin T Wall; Bas van de Valk; Tanya M Holloway; Graham P Holloway; Adrian Chabowski; Gijs H Goossens; Luc J C van Loon
Journal:  Diabetes       Date:  2016-06-29       Impact factor: 9.461

Review 4.  Could Ceramides Become the New Cholesterol?

Authors:  Scott A Summers
Journal:  Cell Metab       Date:  2018-01-04       Impact factor: 27.287

5.  Weight-Loss Diets, Adiponectin, and Changes in Cardiometabolic Risk in the 2-Year POUNDS Lost Trial.

Authors:  Wenjie Ma; Tao Huang; Yan Zheng; Molin Wang; George A Bray; Frank M Sacks; Lu Qi
Journal:  J Clin Endocrinol Metab       Date:  2016-04-07       Impact factor: 5.958

Review 6.  Bed rest and accelerated aging in relation to the musculoskeletal and cardiovascular systems and frailty biomarkers: A review.

Authors:  D S Kehler; O Theou; K Rockwood
Journal:  Exp Gerontol       Date:  2019-06-28       Impact factor: 4.032

7.  Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.

Authors:  D R Matthews; J P Hosker; A S Rudenski; B A Naylor; D F Treacher; R C Turner
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

8.  DGAT1 expression increases heart triglyceride content but ameliorates lipotoxicity.

Authors:  Li Liu; XiaoJing Shi; Kalyani G Bharadwaj; Shota Ikeda; Haruyo Yamashita; Hiroaki Yagyu; Jean E Schaffer; Yi-Hao Yu; Ira J Goldberg
Journal:  J Biol Chem       Date:  2009-09-24       Impact factor: 5.157

9.  The Clamp-Like Index: a novel and highly sensitive insulin sensitivity index to calculate hyperinsulinemic clamp glucose infusion rates from oral glucose tolerance tests in nondiabetic subjects.

Authors:  Christian Anderwald; Marietta Anderwald-Stadler; Miriam Promintzer; Gerhard Prager; Martina Mandl; Peter Nowotny; Martin G Bischof; Michael Wolzt; Bernhard Ludvik; Thomas Kästenbauer; Giovanni Pacini; Anton Luger; Michael Krebs
Journal:  Diabetes Care       Date:  2007-06-26       Impact factor: 19.112

10.  One Week of Hospitalization Following Elective Hip Surgery Induces Substantial Muscle Atrophy in Older Patients.

Authors:  Imre W K Kouw; Bart B L Groen; Joey S J Smeets; Irene Fleur Kramer; Janneau M X van Kranenburg; Rachél Nilwik; Jan A P Geurts; René H M Ten Broeke; Martijn Poeze; Luc J C van Loon; Lex B Verdijk
Journal:  J Am Med Dir Assoc       Date:  2018-08-11       Impact factor: 4.669

View more
  6 in total

1.  Pretransplant Systemic Lipidomic Profiles in Allogeneic Stem Cell Transplant Recipients.

Authors:  Kimberley Joanne Hatfield; Øystein Bruserud; Håkon Reikvam
Journal:  Cancers (Basel)       Date:  2022-06-13       Impact factor: 6.575

2.  Characterizing a Common CERS2 Polymorphism in a Mouse Model of Metabolic Disease and in Subjects from the Utah CAD Study.

Authors:  Rebekah J Nicholson; Annelise M Poss; J Alan Maschek; James E Cox; Paul N Hopkins; Steven C Hunt; Mary C Playdon; William L Holland; Scott A Summers
Journal:  J Clin Endocrinol Metab       Date:  2021-07-13       Impact factor: 6.134

Review 3.  Ceramides and Ceramide Scores: Clinical Applications for Cardiometabolic Risk Stratification.

Authors:  Mika Hilvo; Vlad C Vasile; Leslie J Donato; Reini Hurme; Reijo Laaksonen
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-29       Impact factor: 5.555

Review 4.  The Role of Ceramides in Diabetes and Cardiovascular Disease Regulation of Ceramides by Adipokines.

Authors:  Bianca C Field; Ruth Gordillo; Philipp E Scherer
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-02       Impact factor: 5.555

5.  Effects of Omega-3 and Antioxidant Cocktail Supplement on Prolonged Bed Rest: Results from Serum Proteome and Sphingolipids Analysis.

Authors:  Pietro Barbacini; Dieter Blottner; Daniele Capitanio; Gabor Trautmann; Katharina Block; Enrica Torretta; Manuela Moriggi; Michele Salanova; Cecilia Gelfi
Journal:  Cells       Date:  2022-07-05       Impact factor: 7.666

Review 6.  Circulating Ceramides- Are Origins Important for Sphingolipid Biomarkers and Treatments?

Authors:  Michael Mah; Mark Febbraio; Sarah Turpin-Nolan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-27       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.